BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7597337)

  • 1. [Prolymphocytic leukemia, description of 2 cases].
    Cabrera ME; Labra S; Andrade W; Ossandón E; Barriga F
    Rev Med Chil; 1994 Sep; 122(9):1052-5. PubMed ID: 7597337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell prolymphocytic leukemia expressing discordant myeloid-associated antigens in simultaneous specimens from bone marrow and peripheral blood.
    Emery CL; Cleveland RP
    Cytometry; 1995 Sep; 22(3):243-9. PubMed ID: 8556956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
    Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
    Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
    Tamayose K; Sato N; Ando J; Sugimoto K; Oshimi K
    Am J Hematol; 2002 Dec; 71(4):331-5. PubMed ID: 12447967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolymphocytic leukaemia--report of three cases.
    Nayak KS; Narayanan S; Naik R; Khadilkar UN
    Indian J Pathol Microbiol; 2003 Jul; 46(3):459-61. PubMed ID: 15025306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
    Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
    Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
    Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin.
    Nguyen-Khac F; Davi F; Receveur A; Maloum K; Morel V; Le Garff-Tavernier M; Ong J; Berger R; Leblond V; Merle-Béral H
    Cancer Genet Cytogenet; 2005 May; 159(1):74-8. PubMed ID: 15860362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prolymphocytic B-cell leukemia with fatal acute liver failure. A case report].
    Steidl L; Rossi A; Cornaggia M; Crippa G; Venco A
    Recenti Prog Med; 1994 Mar; 85(3):186-9. PubMed ID: 8184202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis].
    Ly B; Hammerstrøm J; Bergheim J; Dahl IM; Grøttum KA; Lødemel B; Baklien K; Smeland E
    Tidsskr Nor Laegeforen; 1998 Jan; 118(2):233-7. PubMed ID: 9485618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolymphocytic leukaemia--report of three cases.
    Nayak KS; Shankarnarayanan ; Naik R; Khadilkar UN
    J Indian Med Assoc; 2004 Jul; 102(7):379-80. PubMed ID: 15717584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic and idiotypic characterisation of the leukaemic B-cells from patients with prolymphocytic leukaemia: evidence for a selective expression of immunoglobulin variable region (IGV) gene products.
    Shokri F; Mageed RA; Richardson P; Jefferis R
    Leuk Res; 1993 Aug; 17(8):669-76. PubMed ID: 8355511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of vascular endothelial growth factor in T-cell prolymphocytic leukemia.
    Ogasawara T; Narita C; Kawauchi K
    Leuk Res; 2007 Mar; 31(3):403-6. PubMed ID: 16620970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
    Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
    Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Translocation t(11;14) (q13;q32) in six patients with lymphoid malignancies of mature B-cell phenotype].
    Takashima T; Nishida K; Taniwaki M; Horiike S; Misawa S; Inaba T; Shimazaki C; Aozasa K; Abe T; Kashima K
    Rinsho Ketsueki; 1994 Feb; 35(2):107-13. PubMed ID: 8139108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment by ranimustine (MCNU) of a patient with B-cell prolymphocytic leukemia (B-PLL)].
    Wake A; Yamasaki Y; Ogawa R; Mori N; Nagata K; Nakata K; Misago M; Izumi Y; Fujita K; Oda S
    Rinsho Ketsueki; 1993 Nov; 34(11):1464-9. PubMed ID: 8254909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.